Enter Note
Done
Go to previous page in this tab
Session
Population
Real-World Impact of GLP1-Based Therapies in CKM Syndrome
calendar_today
Schedule
edit_square
Notes
editor_choice
Credits
Sun, Nov 08
Moderated Digital Poster 19‚ Population Science Zone
11:50am - 1:05pm (Central)
CK.MDP.06
Set Timezone
Timezone
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
PT - Pacific Time
(GMT-07:00) Arizona
MT - Mountain Time
CT - Central Time
ET - Eastern Time
(GMT-05:00) Indiana (East)
—————————–
(GMT-12:00) International Date Line West
(GMT-11:00) Midway Island
(GMT-11:00) Samoa
(GMT-08:00) Tijuana, Baja California
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-06:00) Saskatchewan
(GMT-06:00) Central America
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-05:00) Bogota
(GMT-05:00) Lima
(GMT-05:00) Rio Branco
(GMT-04:30) Caracas
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Manaus
(GMT-04:00) Santiago
(GMT-04:00) La Paz
(GMT-03:30) Newfoundland
(GMT-03:00) Georgetown
(GMT-03:00) Brasilia
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT) Dublin
(GMT) Lisbon
(GMT) London
(GMT) Monrovia
(GMT) Reykjavik
(GMT) Casablanca
(GMT+01:00) Belgrade
(GMT+01:00) Bratislava
(GMT+01:00) Budapest
(GMT+01:00) Ljubljana
(GMT+01:00) Prague
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Warsaw
(GMT+01:00) Zagreb
(GMT+01:00) Brussels
(GMT+01:00) Copenhagen
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) West Central Africa
(GMT+01:00) Amsterdam
(GMT+01:00) Berlin
(GMT+01:00) Rome
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+02:00) Minsk
(GMT+02:00) Cairo
(GMT+02:00) Helsinki
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Istanbul
(GMT+02:00) Jerusalem
(GMT+02:00) Amman
(GMT+02:00) Beirut
(GMT+02:00) Windhoek
(GMT+02:00) Harare
(GMT+02:00) Johannesburg
(GMT+03:00) Kuwait
(GMT+03:00) Riyadh
(GMT+03:00) Baghdad
(GMT+03:00) Nairobi
(GMT+03:00) Tbilisi
(GMT+03:00) Moscow
(GMT+03:00) Volgograd
(GMT+03:30) Tehran
(GMT+04:00) Muscat
(GMT+04:00) Baku
(GMT+04:00) Yerevan
(GMT+05:00) Ekaterinburg
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Calcutta
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Dhaka
(GMT+06:00) Almaty
(GMT+06:00) Novosibirsk
(GMT+06:30) Yangon (Rangoon)
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Bangkok
(GMT+07:00) Jakarta
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Urumqi
(GMT+08:00) Irkutsk
(GMT+08:00) Ulaan Bataar
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Perth
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Darwin
(GMT+09:30) Adelaide
(GMT+10:00) Canberra
(GMT+10:00) Melbourne
(GMT+10:00) Sydney
(GMT+10:00) Brisbane
(GMT+10:00) Hobart
(GMT+10:00) Vladivostok
(GMT+10:00) Guam
(GMT+10:00) Port Moresby
(GMT+11:00) Magadan
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Auckland
(GMT+13:00) Nukualofa
location_on
View Map
Mandeep Bajaj
MBBS
Baylor College of Medicine
Generic 'disconnected' Message
Real-World Impact of GLP1-based therapies in CKM syndrome
Communities
Cardiovascular Kidney Metabolic Health
Navigation
Population
Session Type
Moderated Digital Poster Session
Onsite Viewing
Live In-Person
Moderated Digital Poster Silent Listening
Real-World Impact of GLP1-Based Therapies in CKM Syndrome
Presentations
Presentation
Population
Effect of Orforglipron on Resolution of Metabolic Syndrome: Post-Hoc Analysis from the ATTAIN-1 and ATTAIN-2 Trials
11:50am-11:55am Nov 8 (Central)
Alice Cheng, Elif Ekinci, Sanja Giljanovic Kis, Tanya Irani, Xiaojuan Mi, Donna Mojdami, Naveed Sattar, Wenyu Ye
Presentation
Population
Q&A
11:55am-11:57am Nov 8 (Central)
Presentation
Population
Post-Myocardial Infarction GLP-1 Receptor Agonist Initiation and Incident Dementia in Type 2 Diabetes: A Propensity-Matched Cohort Study
11:57am-12:02pm Nov 8 (Central)
Muhammad Asim Agha, Muhammad Junaid Azhar, Wardah Bajwa, Abdulkarim Ben Yezza, Miriam Michael, Muhammad Sajawal, Shahzad Zafar
Presentation
Population
Q&A
12:02pm-12:04pm Nov 8 (Central)
Presentation
Population
Cardiovascular Outcomes of Oral versus Injectable Semaglutide: A Propensity-Matched Real-World Cohort Study
12:04pm-12:09pm Nov 8 (Central)
Bernard Evenhuis, Jacob Hicks, Jose Ramon Medina Inojosa, Celine Mouawad, Austin Rim, Eric Santana, Amit Shah, Vishrut Thaker
Presentation
Population
Q&A
12:09pm-12:11pm Nov 8 (Central)
Presentation
Population
Glucagon-Like Peptide-1 Receptor Agonists and Clinical Outcomes in Antipsychotic-Treated Patients with Schizophrenia and Obesity: A Target Trial Emulation
12:11pm-12:16pm Nov 8 (Central)
Kuan Yu Chi, Christopher Chinnatambi, Ishmum Chowdhury, Mark Costa, Abdulla Damluji, Chidubem Ezenna, Sammudeen Ibrahim, Sridhar Mangalesh, Abdul Daaim Mohammed-Murtala, Michael Nanna, Armin Nouri, Parvaneh Rastgou, Raiza Rossi
Presentation
Population
Q&A
12:16pm-12:18pm Nov 8 (Central)
Presentation
Population
Trajectory of Predicted 10-year Cardiovascular Disease Risk with Tirzepatide Dose Modifications: A Post-Hoc Analysis from the SURMOUNT-MAINTAIN Trial
12:18pm-12:23pm Nov 8 (Central)
Avigdor Arad, Sagar Das, Michael Honigberg, Clare Lee, Kristina Lewis, Runjia Li, Hong Liu-Seifert, Mamas Mamas, Navneet Upadhyay
Presentation
Population
Q&A
12:23pm-12:25pm Nov 8 (Central)
Presentation
Population
Glucagon-Like Peptide-1 Receptor Agonists versus Metformin for Glycemic Control and Cardiovascular Risk Reduction in Adults with Prediabetes and Obesity
12:25pm-12:30pm Nov 8 (Central)
Said Alsidawi, Reza Arsanjani, Chadi Ayoub, Hari Chaliki, Allah Dad, Vinicius de Sousa Barzon Serra, Juan Farina, Abdelrahman Hafez, Ramzi Ibrahim, Steven Lester, Hoang Nhat Pham, Luis Scott, Julia Zanco
Presentation
Population
Q&A
12:30pm-12:32pm Nov 8 (Central)
Presentation
Population
Comparative Effectiveness and Safety of Tirzepatide versus Semaglutide in Adolescents and Young Adults with Obesity: A Nationwide Retrospective Cohort Study
12:32pm-12:37pm Nov 8 (Central)
Kyungseon Choi, Chungsoo Kim, Harlan Krumholz, Yuan Lu, Mona Sharifi, Michelle Van Name
Presentation
Population
Q&A
12:37pm-12:39pm Nov 8 (Central)
Presentation
Population
GLP-1 Receptor Agonists Reduce Mortality and Cardiovascular Events in Serious Mental Illness: A Multinational Target Trial of 1.5 Million Adults
12:39pm-12:44pm Nov 8 (Central)
Angela Kwan, Roger McIntyre
Presentation
Population
Q&A
12:44pm-12:46pm Nov 8 (Central)
Presentation
Population
Q&A
12:51pm-12:53pm Nov 8 (Central)
Presentation
Population
Comparative Cardiovascular Efficacy of Tirzepatide versus GLP-1 Receptor Agonists: A Network Meta-Analysis of Randomized Controlled Trials
12:53pm-12:58pm Nov 8 (Central)
Muhammad Awais Bin Abdul Malik, Muhammad Mubasher Haneef, Ravesh Kumar, - Namal, Ayesha Nawal, Hareem Saleem, Junaid Saleem, Maryam Shahid, Muhammad Waseem Tahir, Zubia Tahir, Shariq Ahmad Wani
Presentation
Population
Q&A
12:58pm-1:00pm Nov 8 (Central)
Presentation
Population
Q&A
1:00pm-1:05pm Nov 8 (Central)
